Dat meldt het wetenschappelijke tijdschrift New Scientist. Meticilline-resistente Staphylococcus aureus (MRSA) staat bekend als de lastige ziekenhuisbacterie, maar S. aureus is ook een beruchte ...

Resistance development of MRSA has become a global health problem. New resistance types, such as vancomycin-resistant S. aureus, have been recently developed. Novel antibiotics, such as linezolid ...

The new research, led by the University of Sheffield, reveals MRSA has a double defence mechanism against antibiotics - this new insight offers hope in treating the life-threatening superbug and ...

It was in this setting—with a recent increase in CA-MRSA skin abscesses ... How should this new evidence change practice? A strategy of routinely treating all skin abscesses with adjunctive ...

Despite the antibacterial effect on MRSA and the multiple biological activities ... Natural resources represent an enormous source for the search for new antimicrobial agents. Pure compounds isolated ...

This marks Zevtera as the sole FDA-approved MRSA-targeting cephalosporin antibiotic for these conditions. It is also indicated for acute bacterial skin and skin structure infections (ABSSSI) and ...

aureus. Several new antibiotics such as linezolid, tigecycline and daptomycin, among others, are now available for the management of cSSSI. Other agents are under investigation and should be ...

The methicillin resistant staphylococcus aureus (MRSA) superbug is notoriously resistant to antibiotic treatments and causes 120,000 deaths each year. The new findings, which were published in the ...

Methicillin-resistant Staphylococcus aureus (MRSA) is a type of bacteria that is resistant to many antibiotics, making infections difficult to treat. Surveillance of MRSA is crucial in healthcare ...

Testing market is projected to expand steadily over the next decade, rising from an estimated USD 4.3 billion in 2025 to USD ...